C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd I
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Cache Capital Corp. (NASDAQ: CCCC) | Delayed: 3.18 +0.01 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $0.30 | |||
| Open | $3.13 | 52 Week Low | $0.30 | |||
| Day High | $3.25 | P/E | N/A | |||
| Day Low | $3.12 | EPS | $0.00 | |||
| Volume | 1,692,803 | |||||
